ACM
LLY icon

Aspen Capital Management’s Eli Lilly LLY Stock Holding History

Aspen Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Buy
323
+3
+0.9% +$3.06K 0.09% 59
2026
Q1 		$294K Hold
320
– – 0.07% 57
2025
Q4 		$344K Hold
320
– – 0.09% 55
2025
Q3 		$244K Hold
320
– – 0.06% 68
2025
Q2 		$249K Hold
320
– – 0.07% 59
2025
Q1 		$264K Buy
+320
New +$266K 0.08% 51

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aspen Capital Management's LLY Position: Q2 2026 in Review

Aspen Capital Management increased its Eli Lilly (LLY) stake by 0.94% in Q2 2026, buying an estimated $3.06K and bringing the position to 323 shares worth $387K. The position accounts for 0.09% of the portfolio, ranked #59.

Aspen Capital Management first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aspen Capital Management held 323 shares of Eli Lilly worth $387K as of Q2 2026.
  • Aspen Capital Management bought 3 Eli Lilly shares in Q2 2026, an estimated $3.06K.
  • Eli Lilly made up 0.09% of Aspen Capital Management's portfolio in Q2 2026, its #59 holding.
  • Aspen Capital Management first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aspen Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.